admin Indian Healthcare industry is growing at a higher pace owing to its strengthening coverage, services and increasing expenditure by public as well as private players. However, receiving health services according to need at the right time and in the right place is being imperative. To provide high-quality treatments, a better understanding of the disease is crucial. Clinical research plays a major role in developing new treatments as well as testing and demonstrating effectiveness.
Founded in 2013, Croissance Clinical Research (CCR) applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments. Today, the company has become an ISO 9001: 2015 Certified organization with a large network of investigators (6000+) in public & private hospitals across India.
[mks_col] [mks_one_half]At Croissance, we work together, we collaborate with every client to offer a tailored approach to fit the project needs[/mks_one_half] [mks_one_half]
“We provide flexible and accurate data management solutions that ensure integrity, accuracy, reliability, cost effectiveness and speed. Our teams have extensive experience across various data management tools along with different clinical phases. Above all, we believe in delivering in time and every time,” explores Satish Marukurthi, CEO of Croissance.
[/mks_one_half] [/mks_col]An Adept Leader Augmenting Clinical Research
Mr. Satish Marukurthi, Founder & CEO of Croissance Clinical Research is an endeavoring strategic professional having two decades of an accomplished global career with a successful track record of establishing and growing businesses to a considerable scale. He has been largely involved in building, shaping and providing innovative strategies for the augmentation of the pharmaceutical industry. His leadership acumen encapsulates almost every business imperatives of organization-people-process-technology nexus associated with running and managing a global business delivery outfit.
Recently, Mr. Satish Marukurthi has been awarded the most prestigious award of the “Pharma Leaders Innovative Leadership in Clinical Research 2019” at Pharma Leaders Power Brand Awards 2019. He is instrumental and playing an active role in the development and growth of Croissance. He is responsible for managing the business operations of Croissance and focused on the constant evolution of the organization, client satisfaction, and long-term relationships.
CCR’s Respiratory Expertise and Experience
Chronic Obstructive Pulmonary Disease (COPD) is predicted to be the third leading cause of death in 2030. In Asia Pacific and India, asthma and COPD are particularly relevant as risk factors such as smoking, biomass fuels, pollution, and tuberculosis (TB) are higher than other regions. Croissance Clinical Research (CCR) has achieved valuable experience in conducting respiratory studies, stretching from protocol writing to conducting end to end studies. Nearly three fourth of their experience has been in the two most prevalent airway diseases – Asthma and COPD. In the past three years, they have been part of 14+ respiratory studies involving nearly 2500 patients at 70+ sites along with conducting 4 respiratory device studies. CCR’s Investigator database comprises 250+ investigators across India with expertise in the respiratory.
CCR’s experienced team of Data Management, Clinical Operations, Project Management, and Medical Affairs professionals are well-versed in managing and monitoring the procedures associated with objectives and end points in respiratory protocols. Their deep respiratory expertise and focused operational staff enables them to fill and complete clinical trials in the best possible time, they maintain a network of research associates, investigators and trial sites with specific experience in pulmonary indications enabling them to provide rapid feasibility and help to meet the respiratory trial goals.
“With our therapeutic and clinical expertise, we focus together on your needs, and strategically customized services for each project allowing you to make decisions quickly and move your development programs forward at an express pace,” expresses Satish.
CCR’s Experience in Vaccine Studies
CCR’s Investigator database comprises 200+ investigators across India with expertise in the Vaccine studies. Also, their experienced team is highly trained in managing and monitoring the procedures associated with objectives and end points in Vaccine protocols.
Maintaining deadlines are often determined by seasonality or the spread of disease. Besides, it is difficult to compress timelines in the stages of vaccine development and production. Croissance Clinical Research has optimized many of the time-critical operational processes in clinical trials of vaccines to make your vaccine reach market at the earliest. CCR understands the unique challenges associated with vaccine development and takes your objectives to heart.
CCR has been part of 15+ vaccine studies involving nearly 10157 patients at 120+ sites.
Croissance Clinical Research Team
Croissance has a diverse, talented team of clinical development professionals who have been exceeding Client expectations. Croissance experts can help you in making smarter decisions and more confident choices. Their high percentage of repeat and referral business is evidence that they have earned client confidence and loyalty.
“Our leading milestone in a short span of time has been to be a part of multiple successful phase III trials and getting the marketing, manufacturing approvals for the drugs, vaccines, and medical devices. It is Croissance’s endeavor to become a reliable service provider globally for small and midsize pharmaceutical and biotech companies. Croissance Clinical Research’s passion and drive for excellence are strong, and we are optimistic about the future of our company and the industry. We envision being a CRO with operations in US and Europe by 2021,” said Satish Marukurthi, CEO of Croissance.
Offering Best and Dedicated Services
“Our journey was not a bed of roses, Croissance has passed through many footraces and our first project started with auditing a site. We have been providing many standalone services as well, and our first end to end project was worth of 80 lakhs. Irrespective of the size of the projects offered to us, our team has dedicatedly provided quality service to all the clients,” Croissance.
With the right people and broad-based expertise, CCR has long standing therapeutic experience and a depth of clinical trial knowledge. In the near future, the company is expecting to become a globally recognized brand among CRO industry.
Magazine
